客服热线:18202992950

Ester compound and medicinal use thereof 发明申请

2023-03-04 2650 13547K 0

专利信息

申请日期 2025-07-12 申请号 AU2005248950
公开(公告)号 AU2005248950A1 公开(公告)日 2006-01-19
公开国别 AU 申请人省市代码 全国
申请人 JAPAN TOBACCO INC
简介 A novel therapeutic agent for hyperlipidemia, which is an ester compound represented by the formula (i") R3 R 4 (I ") (wherein R z and R 2 are each hydrogen atom or optionally substituted aryl, etc.; X is -CO0or -CON(RI°)-; Rand Rare each hydrogen atom, Ci-C 6 alkyl or Ci-C 6 alkoxy, etc.; R 5, R 6 and R 7 are each hydrogen atom, CI-C 6 alkyl or CI-C 6 alkoxy, etc.; RSand R 9 are each independently hydrogen atom, Ci-C 6 alkyl, -CON(RIS)(R 19) or -COO(RZ°), etc.; ring A, ring B and ring C are each independently aryl or heterocycle residue, etc.; Alk I and Alk 2 are each independently.alkanediyl, etc.; 1 and m are each an integer of 0 or i to 3) or a prodrug thereof, or a pharmaceutically acceptable salt of either. The therapeutic agent selectively inhibits MTP in the small intestine, thus causes no such side effect as a fatty


您还没有登录,请登录后查看下载地址


反对 0举报 0 收藏 0 打赏 0评论 0
下载排行
网站首页  |  关于我们  |  联系方式  |  使用协议  |  版权隐私  |  网站地图  |  排名推广  |  广告服务  |  积分换礼  |  网站留言  |  RSS订阅  |  违规举报  |  京ICP备2021025988号-4